Published in Medicine (Baltimore) on August 01, 2015
Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting. J Gastroenterol (2016) 0.75
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept. PLoS One (2017) 0.75
Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer. Cancer Med (2017) 0.75
Portal vein/superior mesenteric vein resection in pancreatic cancer treatment in the elderly. Medicine (Baltimore) (2017) 0.75
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg (2001) 8.34
Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg (1985) 7.14
Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol (2006) 4.50
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 4.34
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg (2007) 4.09
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg (1997) 3.90
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol (2008) 3.51
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 3.45
Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg (2008) 3.36
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol (2009) 3.22
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol (2008) 3.15
Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg (1992) 2.98
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol (1997) 2.75
Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy. Cancer (1976) 2.63
Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg (2007) 2.48
Regional resection of cancer of the pancreas: a new surgical approach. Surgery (1973) 2.43
Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg (2003) 2.26
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol (2006) 2.10
Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg (1984) 2.03
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer (2004) 2.00
Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2012) 1.97
Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg (1996) 1.93
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer. Ann Surg Oncol (2005) 1.88
Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol (1998) 1.72
Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg (1999) 1.65
Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery (1992) 1.59
Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"? J Gastrointest Surg (2013) 1.52
Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. J Clin Oncol (2002) 1.40
Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg (1996) 1.36
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol (2013) 1.36
Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg (2006) 1.32
Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol (1998) 1.29
AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: rationale and overview of the conference. Ann Surg Oncol (2009) 1.29
Indications and techniques of extended resection for pancreatic cancer. World J Surg (2006) 1.28
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer (2013) 1.16
Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg (1994) 1.13
Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma. J Am Coll Surg (2007) 1.09
CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.07
Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer. J Gastrointest Surg (2011) 1.03
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome. Int J Gastrointest Cancer (2003) 1.01
Vascular reconstruction during pancreatoduodenectomy for ductal adenocarcinoma of the pancreas improves resectability but does not achieve cure. World J Surg (2010) 0.98
Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer. Surg Oncol (2013) 0.92
Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. Br J Cancer (2008) 0.87
Borderline resectable pancreatic cancer: pushing the technical limits of surgery. Bull Am Coll Surg (2013) 0.82
Serous cyst adenoma of the pancreas: appraisal of active surgical strategy before it causes problems. Surg Endosc (2011) 2.19
Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol (2005) 1.95
Ectopic pancreas: CT findings with emphasis on differentiation from small gastrointestinal stromal tumor and leiomyoma. Radiology (2009) 1.69
Robotic total mesorectal excision for rectal cancer using four robotic arms. Surg Endosc (2007) 1.68
Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol (2012) 1.47
[Assessment of the definition of early extrahepatic bile duct cancer through the prognosis analysis who had received curative resection]. Korean J Gastroenterol (2007) 1.43
Conventional laparoscopic and robot-assisted spleen-preserving pancreatectomy: does da Vinci have clinical advantages? Surg Endosc (2010) 1.39
Choledochal cyst and associated malignant tumors in adults: a multicenter survey in South Korea. Arch Surg (2011) 1.33
Solid pseudopapillary tumor of the pancreas suggesting malignant potential. Pancreas (2006) 1.31
The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer. J Surg Res (2007) 1.28
Outcome after curative resection for a huge (>or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg (2009) 1.26
Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol (2007) 1.24
Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT. AJR Am J Roentgenol (2008) 1.23
Clinical validation and risk factors for delayed gastric emptying based on the International Study Group of Pancreatic Surgery (ISGPS) Classification. Surgery (2009) 1.23
Intermediate dose 5-fluorouracil-induced encephalopathy. Jpn J Clin Oncol (2006) 1.23
Transumbilical single port laparoscopic adrenalectomy: a technical report on right and left adrenalectomy using the glove port. Yonsei Med J (2012) 1.20
Ten years of experience with resection of left-sided pancreatic ductal adenocarcinoma: evolution and initial experience to a laparoscopic approach. Surg Endosc (2010) 1.17
Analysis of enhancement pattern of flat gallbladder wall thickening on MDCT to differentiate gallbladder cancer from cholecystitis. AJR Am J Roentgenol (2008) 1.16
Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma. Liver Int (2010) 1.15
Early experiences of robotic-assisted laparoscopic liver resection. Yonsei Med J (2008) 1.13
Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. J Gastroenterol Hepatol (2006) 1.12
Overexpression in Arabidopsis of a plasma membrane-targeting glutamate receptor from small radish increases glutamate-mediated Ca2+ influx and delays fungal infection. Mol Cells (2006) 1.12
Robotic liver resection: technique and results of 30 consecutive procedures. Surg Endosc (2012) 1.11
What is the best treatment modality for adrenal metastasis from hepatocellular carcinoma? J Surg Oncol (2007) 1.11
Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging (2003) 1.10
The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane. Gastrointest Endosc (2005) 1.09
The first korean experience of telemanipulative robot-assisted laparoscopic cholecystectomy using the da vinci system. Yonsei Med J (2007) 1.06
Hepatoid carcinoma of the pancreas combined with neuroendocrine carcinoma. Gut Liver (2010) 1.06
A case of primary bilateral adrenal lymphoma (PAL) with central nervous system (CNS) involvement. Yonsei Med J (2002) 1.04
Robotic radical hysterectomy with pelvic lymphadenectomy for cervical carcinoma: a pilot study. Gynecol Oncol (2007) 1.04
Inflammatory pseudotumor of the liver treated by hepatic resection: a case report. Yonsei Med J (2006) 1.04
Switching monopolar radiofrequency ablation technique using multiple, internally cooled electrodes and a multichannel generator: ex vivo and in vivo pilot study. Invest Radiol (2007) 1.04
Factors influencing recurrence after curative resection for ampulla of Vater carcinoma. J Surg Oncol (2007) 1.04
Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer. J Gastrointest Surg (2011) 1.03
Changes in serum and ascitic monocyte chemotactic protein-1 (MCP-1) and IL-10 levels in cirrhotic patients with spontaneous bacterial peritonitis. J Interferon Cytokine Res (2007) 1.03
Differential diagnosis between gallbladder adenomas and cholesterol polyps on contrast-enhanced harmonic endoscopic ultrasonography. Surg Endosc (2012) 1.03
Transoral robotic surgery (TORS) in laryngeal and hypopharyngeal cancer. J Laparoendosc Adv Surg Tech A (2009) 1.03
The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection. J Surg Oncol (2009) 1.02
Laparoscopic cholecystectomy for treatment of unexpected early-stage gallbladder cancer. J Surg Oncol (2005) 1.02
Initial experiences using robot-assisted central pancreatectomy with pancreaticogastrostomy: a potential way to advanced laparoscopic pancreatectomy. Surg Endosc (2010) 1.01
Laparoscopic major liver resection in Korea: a multicenter study. J Hepatobiliary Pancreat Sci (2013) 1.01
Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography. Eur J Nucl Med Mol Imaging (2004) 1.01
Percutaneous transhepatic cyst drainage as a "bridge procedure" to definitive treatment of perforated choledochal cysts: a case report. Surg Laparosc Endosc Percutan Tech (2008) 1.00
A case of robot-assisted excision of choledochal cyst, hepaticojejunostomy, and extracorporeal Roux-en-y anastomosis using the da Vinci surgical system. Surg Laparosc Endosc Percutan Tech (2007) 1.00
Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria. AJR Am J Roentgenol (2012) 1.00
[Mucinous cholangiocarcinoma associated with Clonorchis sinensis infestation: a case report]. Korean J Hepatol (2004) 1.00
Gallbladder carcinoma associated with anomalous pancreaticobiliary duct junction. Can J Gastroenterol (2007) 1.00
Serum kisspeptin levels in Korean girls with central precocious puberty. J Korean Med Sci (2011) 0.99
Structure-function relationships in normal and glaucomatous eyes determined by time- and spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2010) 0.99
Hepatocellular carcinoma during pregnancy: is hepatocellular carcinoma more aggressive in pregnant patients? J Hepatobiliary Pancreat Sci (2011) 0.98
The first experience of robot assisted spleen-preserving laparoscopic distal pancreatectomy in Korea. Yonsei Med J (2011) 0.98
Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein. FEBS Lett (2002) 0.97
Rectal cancer: comparison of accuracy of local-regional staging with two- and three-dimensional preoperative 3-T MR imaging. Radiology (2010) 0.96
A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2004) 0.96
Laparoscopic resection of retroperitoneal benign schwannoma. J Laparoendosc Adv Surg Tech A (2008) 0.96
Revisiting vascular patency after spleen-preserving laparoscopic distal pancreatectomy with conservation of splenic vessels. Surg Endosc (2012) 0.95
Adrenal cavernous hemangioma: a case report with review of the literature. JOP (2014) 0.95
Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes. Surg Endosc (2014) 0.94
[A case of gangliocytic paraganglioma in duodenum]. Korean J Gastroenterol (2004) 0.94
Two cases of portal annular pancreas. Korean J Gastroenterol (2012) 0.94
Is it worthwhile to preserve adult spleen in laparoscopic distal pancreatectomy? Perioperative and patient-reported outcome analysis. Surg Endosc (2012) 0.94
Robot-assisted spleen-preserving distal pancreatectomy: a single surgeon's experiences and proposal of clinical application. Surg Endosc (2012) 0.93
Comparison of the sixth and seventh editions of the AJCC TNM classification for gallbladder cancer. J Gastrointest Surg (2013) 0.93
The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Invest Radiol (2008) 0.92
Hepatic radiofrequency ablation using multiple probes: ex vivo and in vivo comparative studies of monopolar versus multipolar modes. Korean J Radiol (2006) 0.92
Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis. J Surg Oncol (2008) 0.92
Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol (2013) 0.92
Single-fulcrum laparoscopic cholecystectomy: a single-incision and multi-port technique. ANZ J Surg (2012) 0.92
Quality of life and mental health in family caregivers of patients with terminal cancer. Support Care Cancer (2011) 0.92